deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT00927706

Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial (ATUTI)

Experimental Control Investigation of the Impact of an Assistive Technology Updating and Tune up Intervention on the User-caregiver Dyad: a Multi-site Trial

Sponsor: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Updated 5 times since 2017 Last updated: Feb 14, 2014 Started: Jun 30, 2009 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Mobility Limitations, this trial is completed. The trial is conducted by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Data source: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

For direct contact, visit the study record on ClinicalTrials.gov .